Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | %Female (2006) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 1.847 Q1 | 202 | 249 | 597 | 33893 | 3484 | 562 | 5.59 | 136.12 | 30.52 | |
2 | Current Drug Targets | journal | 1.512 Q2 | 119 | 161 | 224 | 19288 | 997 | 205 | 4.41 | 119.80 | 29.90 | |
3 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.464 Q2 | 108 | 47 | 137 | 4962 | 589 | 131 | 4.18 | 105.57 | 35.11 | |
4 | Current Gene Therapy | journal | 1.267 Q2 | 80 | 46 | 138 | 6424 | 615 | 134 | 4.49 | 139.65 | 35.11 | |
5 | Mini-Reviews in Medicinal Chemistry | journal | 0.975 | 107 | 141 | 272 | 11742 | 944 | 257 | 3.60 | 83.28 | 30.16 | |
6 | Infectious Disorders - Drug Targets | journal | 0.965 Q3 | 61 | 27 | 95 | 3047 | 276 | 88 | 2.68 | 112.85 | 41.43 | |
7 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.818 Q3 | 45 | 25 | 112 | 3028 | 290 | 104 | 2.58 | 121.12 | 32.00 | |
8 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.378 Q4 | 39 | 20 | 85 | 3837 | 93 | 79 | 1.31 | 191.85 | 49.06 | |
9 | Letters in Drug Design and Discovery | journal | 0.227 Q4 | 37 | 114 | 99 | 4853 | 71 | 99 | 0.72 | 42.57 | 34.96 | |
10 | Current Cancer Therapy Reviews | journal | 17 | 31 | 0 | 3491 | 0 | 0 | 0.00 | 112.61 | 45.71 | ||
11 | Current Computer-Aided Drug Design | journal | 32 | 28 | 0 | 2884 | 0 | 0 | 0.00 | 103.00 | 19.05 | ||
12 | Current Enzyme Inhibition | journal | 19 | 29 | 0 | 4245 | 0 | 0 | 0.00 | 146.38 | 44.12 | ||
13 | Current Pharmaceutical Analysis | journal | 27 | 32 | 0 | 3266 | 0 | 0 | 0.00 | 102.06 | 29.35 | ||
14 | Frontiers in Drug Design and Discovery | book series | 9 | 18 | 0 | 1416 | 0 | 0 | 0.00 | 78.67 | 28.26 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®